ProfileGDS4718 / 233866_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 22% 20% 33% 19% 19% 17% 22% 24% 12% 19% 17% 18% 12% 20% 19% 22% 17% 19% 15% 30% 19% 20% 32% 20% 21% 22% 17% 18% 18% 19% 16% 17% 14% 23% 19% 19% 18% 22% 21% 26% 25% 17% 17% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2425822
GSM549102patient 115, normal, homogenized [OPG study]4.1572920
GSM549104patient 119, normal, homogenized [OPG study]4.6452933
GSM549108patient 138, normal, homogenized [OPG study]4.1528119
GSM549119patient 077, normal, homogenized [OPG study]4.0923919
GSM549133patient 032, cancer, homogenized [OPG study]3.9892617
GSM549139patient 042, cancer, homogenized [OPG study]4.1839222
GSM549099patient 107, normal, homogenized [OPG study]4.3355824
GSM549109patient 139, normal, homogenized [OPG study]3.8878412
GSM549110patient 046, normal, homogenized [OPG study]4.1175619
GSM549114patient 063, normal, homogenized [OPG study]4.0132217
GSM549122patient 082, normal, homogenized [OPG study]4.0805318
GSM549134patient 033, cancer, homogenized [OPG study]3.8379112
GSM549136patient 036, cancer, homogenized [OPG study]4.1022120
GSM549140patient 044, cancer, homogenized [OPG study]4.0724919
GSM549111patient 047, normal, homogenized [OPG study]4.1880522
GSM549113patient 057, normal, homogenized [OPG study]4.0009917
GSM549132patient 031, cancer, homogenized [OPG study]4.0973619
GSM549137patient 038, cancer, homogenized [OPG study]3.9589215
GSM549142patient 047, cancer, homogenized [OPG study]4.6631530
GSM549100patient 110, normal, homogenized [OPG study]4.1078919
GSM549107patient 135, normal, homogenized [OPG study]4.1134520
GSM549115patient 068, normal, homogenized [OPG study]4.555632
GSM549116patient 072, normal, homogenized [OPG study]4.1382420
GSM549120patient 078, normal, homogenized [OPG study]4.1932321
GSM549131patient 030, cancer, homogenized [OPG study]4.1712922
GSM549118patient 074, normal, homogenized [OPG study]4.0504517
GSM549129patient 027, cancer, homogenized [OPG study]4.0896618
GSM549123patient 088, normal, homogenized [OPG study]4.0548118
GSM549124patient 006, cancer, homogenized [OPG study]4.1502519
GSM549126patient 015, cancer, homogenized [OPG study]3.9882516
GSM549128patient 025, cancer, homogenized [OPG study]4.0245117
GSM549103patient 117, normal, homogenized [OPG study]3.9557714
GSM549117patient 073, normal, homogenized [OPG study]4.2425823
GSM549138patient 041, cancer, homogenized [OPG study]4.0802919
GSM549141patient 045, cancer, homogenized [OPG study]4.0534819
GSM549130patient 028, cancer, homogenized [OPG study]4.0681118
GSM549101patient 111, normal, homogenized [OPG study]4.2251222
GSM549105patient 128, normal, homogenized [OPG study]4.2152621
GSM549106patient 134, normal, homogenized [OPG study]4.3119226
GSM549112patient 048, normal, homogenized [OPG study]4.3223325
GSM549125patient 011, cancer, homogenized [OPG study]4.026717
GSM549127patient 024, cancer, homogenized [OPG study]4.0279917
GSM549135patient 035, cancer, homogenized [OPG study]4.0620619